FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022159748> ?p ?o ?g. }

• W2022159748 endingPage "e76388" @default.
• W2022159748 startingPage "e76388" @default.
• W2022159748 abstract "Background and Aims Transcatheter intraarterial techniques can effectively deliver chemotherapeutic agents to tumor and improve the efficacy of chemotherapy. The present study is designed to evaluate the effect of transcatheter intraarterial techniques on the distribution of doxorubicin in relation to blood vessels in liver cancer. Methods VX2 tumors were implanted in the livers of 32 rabbits. The animals were divided into 4 groups of 8 animals each. Group 1 (doxo iv) animals received doxorubicin intravenous injection; group 2 (doxo ia) received doxorubicin hepatic intraarterial infusion; group 3 (doxo ia + E) received doxorubicin hepatic intraarterial infusion followed by embolization; group 4 (doxo + L ia + E) received hepatic intraarterial infusion of doxorubicin mixed with Lipiodol followed by embolization. Ten minutes or 4 hours after treatment, the animals were sacrificed and tumors were sampled. Immunofluorescence techniques were used to evaluate the distribution of doxorubicin in relation to blood vessels. Results Doxorubicin fluorescence was distributed around tumor blood vessels and decreased with distance from the blood vessels. Tumor cells in avascular and adjacent regions were not exposed to detectable concentrations of doxorubicin. Tumors in the group 2, 3 and 4 had a significant increase in doxorubicin penetration compared with the group 1 tumors (P<0.05). Among the three groups of transcatheter therapies, doxorubicin penetration distance in group 3 was significantly larger than that in group 2 and 4 (P<0.05), and no significant difference was found between group 2 and 4 tumors (P>0.05) at 10 minutes. In contrast, at 4 hours and in total, both group 3 and 4 tumors had significant increases in drug penetration compared with group 2 (P<0.05), and no significant difference was noted between group 3 and 4 tumors (P>0.05). Conclusion Transcatheter intraarterial therapies improve doxorubicin penetration in liver cancer; nevertheless their effect on drug distribution is somewhat limited." @default.
• W2022159748 created "2016-06-24" @default.
• W2022159748 creator A5026226563 @default.
• W2022159748 creator A5026282888 @default.
• W2022159748 creator A5027041701 @default.
• W2022159748 creator A5037195175 @default.
• W2022159748 creator A5040973067 @default.
• W2022159748 creator A5059176162 @default.
• W2022159748 creator A5065739143 @default.
• W2022159748 creator A5066102428 @default.
• W2022159748 creator A5074004731 @default.
• W2022159748 creator A5075012859 @default.
• W2022159748 creator A5088479834 @default.
• W2022159748 creator A5090517776 @default.
• W2022159748 date "2013-10-08" @default.
• W2022159748 modified "2023-10-16" @default.
• W2022159748 title "Effect of Transcatheter Intraarterial Therapies on the Distribution of Doxorubicin in Liver Cancer in a Rabbit Model" @default.
• W2022159748 cites W1593844282 @default.
• W2022159748 cites W1976663416 @default.
• W2022159748 cites W1982525460 @default.
• W2022159748 cites W2012636494 @default.
• W2022159748 cites W2016555632 @default.
• W2022159748 cites W2021261445 @default.
• W2022159748 cites W2022095438 @default.
• W2022159748 cites W2024779730 @default.
• W2022159748 cites W2026735803 @default.
• W2022159748 cites W2033802014 @default.
• W2022159748 cites W2040832143 @default.
• W2022159748 cites W2052552898 @default.
• W2022159748 cites W2056476092 @default.
• W2022159748 cites W2083437069 @default.
• W2022159748 cites W2088826237 @default.
• W2022159748 cites W2093916414 @default.
• W2022159748 cites W2094488950 @default.
• W2022159748 cites W2100016216 @default.
• W2022159748 cites W2111268019 @default.
• W2022159748 cites W2119419566 @default.
• W2022159748 cites W2163050497 @default.
• W2022159748 cites W2171673899 @default.
• W2022159748 cites W2319962899 @default.
• W2022159748 cites W4211105405 @default.
• W2022159748 cites W4231634171 @default.
• W2022159748 doi "https://doi.org/10.1371/journal.pone.0076388" @default.
• W2022159748 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3792963" @default.
• W2022159748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24116106" @default.
• W2022159748 hasPublicationYear "2013" @default.
• W2022159748 type Work @default.
• W2022159748 sameAs 2022159748 @default.
• W2022159748 citedByCount "25" @default.
• W2022159748 countsByYear W20221597482014 @default.
• W2022159748 countsByYear W20221597482015 @default.
• W2022159748 countsByYear W20221597482016 @default.
• W2022159748 countsByYear W20221597482017 @default.
• W2022159748 countsByYear W20221597482018 @default.
• W2022159748 countsByYear W20221597482019 @default.
• W2022159748 countsByYear W20221597482020 @default.
• W2022159748 countsByYear W20221597482021 @default.
• W2022159748 countsByYear W20221597482022 @default.
• W2022159748 crossrefType "journal-article" @default.
• W2022159748 hasAuthorship W2022159748A5026226563 @default.
• W2022159748 hasAuthorship W2022159748A5026282888 @default.
• W2022159748 hasAuthorship W2022159748A5027041701 @default.
• W2022159748 hasAuthorship W2022159748A5037195175 @default.
• W2022159748 hasAuthorship W2022159748A5040973067 @default.
• W2022159748 hasAuthorship W2022159748A5059176162 @default.
• W2022159748 hasAuthorship W2022159748A5065739143 @default.
• W2022159748 hasAuthorship W2022159748A5066102428 @default.
• W2022159748 hasAuthorship W2022159748A5074004731 @default.
• W2022159748 hasAuthorship W2022159748A5075012859 @default.
• W2022159748 hasAuthorship W2022159748A5088479834 @default.
• W2022159748 hasAuthorship W2022159748A5090517776 @default.
• W2022159748 hasBestOaLocation W20221597481 @default.
• W2022159748 hasConcept C110121322 @default.
• W2022159748 hasConcept C121608353 @default.
• W2022159748 hasConcept C126322002 @default.
• W2022159748 hasConcept C126894567 @default.
• W2022159748 hasConcept C134306372 @default.
• W2022159748 hasConcept C141071460 @default.
• W2022159748 hasConcept C2776035437 @default.
• W2022159748 hasConcept C2776231280 @default.
• W2022159748 hasConcept C2776694085 @default.
• W2022159748 hasConcept C2778448856 @default.
• W2022159748 hasConcept C2781303535 @default.
• W2022159748 hasConcept C33923547 @default.
• W2022159748 hasConcept C71924100 @default.
• W2022159748 hasConceptScore W2022159748C110121322 @default.
• W2022159748 hasConceptScore W2022159748C121608353 @default.
• W2022159748 hasConceptScore W2022159748C126322002 @default.
• W2022159748 hasConceptScore W2022159748C126894567 @default.
• W2022159748 hasConceptScore W2022159748C134306372 @default.
• W2022159748 hasConceptScore W2022159748C141071460 @default.
• W2022159748 hasConceptScore W2022159748C2776035437 @default.
• W2022159748 hasConceptScore W2022159748C2776231280 @default.
• W2022159748 hasConceptScore W2022159748C2776694085 @default.
• W2022159748 hasConceptScore W2022159748C2778448856 @default.
• W2022159748 hasConceptScore W2022159748C2781303535 @default.
• W2022159748 hasConceptScore W2022159748C33923547 @default.
• W2022159748 hasConceptScore W2022159748C71924100 @default.

• next